{"schema_version":"alpha-profile-public-v1","slug":"andrew-r-saik","canonical_url":"https://registry.alpha.ac/people/andrew-r-saik","as_of":"2026-09-18T13:07:57.573019+00:00","published_at":"2026-09-02T02:37:24.229537+00:00","last_reviewed_at":"2026-05-16T01:09:54.504+00:00","identity":{"display_name":"Andrew R. Saik","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Milestone Pharmaceuticals Inc.","company_slug":"milestone-pharmaceuticals-inc","exchange":"NASDAQ","ticker":"MIST","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2024-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1408443/000110465925042640/tm2513454d3_def14a.htm","effective_date":"2025-04-30","last_checked_at":"2026-04-28T23:29:01.942+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=andrew-r-saik","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=andrew-r-saik&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Mr. Saik brings over 25 years of accounting and finance experience at biopharmaceutical companies. He has led private and public companies in developing financial strategies, enhancing financial flexibility and spearheading capital structure transformations resulting in successful mergers and acquisitions."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Milestone Pharmaceuticals Inc.","organizationId":"milestone-pharmaceuticals-inc","title":"Director","period":"2024-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1408443/000110465925042640/tm2513454d3_def14a.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Milestone Pharmaceuticals Inc.","company_slug":"milestone-pharmaceuticals-inc","exchange":"NASDAQ","ticker":"MIST","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2024-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1408443/000110465925042640/tm2513454d3_def14a.htm","effective_date":"2025-04-30","last_checked_at":"2026-04-28T23:29:01.942+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Andrew R. Saik as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:09:54.664867+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"MIST DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1408443/000110465925042640/tm2513454d3_def14a.htm","published_at":"2025-04-30T00:00:00+00:00","last_checked_at":"2026-05-16T01:09:54.556389+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Andrew R. Saik currently serves as Director at Milestone Pharmaceuticals Inc..","claim_state":"verified","valid_from":"2025-04-30","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:09:54.620965+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"MIST DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1408443/000110465925042640/tm2513454d3_def14a.htm","published_at":"2025-04-30T00:00:00+00:00","last_checked_at":"2026-05-16T01:09:54.556389+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Audit"],"claim_text":"Andrew R. Saik serves on Audit.","claim_state":"verified","valid_from":"2025-04-30","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:09:54.639363+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"MIST DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1408443/000110465925042640/tm2513454d3_def14a.htm","published_at":"2025-04-30T00:00:00+00:00","last_checked_at":"2026-05-16T01:09:54.556389+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Arvinas, Inc.","claim_text":"Andrew R. Saik is linked to Arvinas, Inc. as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:09:54.761628+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"MIST DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1408443/000110465925042640/tm2513454d3_def14a.htm","published_at":"2025-04-30T00:00:00+00:00","last_checked_at":"2026-05-16T01:09:54.556389+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Chief Financial Officer","claim_text":"Andrew R. Saik is also listed as Chief Financial Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:09:54.745164+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"MIST DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1408443/000110465925042640/tm2513454d3_def14a.htm","published_at":"2025-04-30T00:00:00+00:00","last_checked_at":"2026-05-16T01:09:54.556389+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Andrew R. Saik as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:09:54.696402+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"MIST DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1408443/000110465925042640/tm2513454d3_def14a.htm","published_at":"2025-04-30T00:00:00+00:00","last_checked_at":"2026-05-16T01:09:54.556389+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Andrew R. Saik as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:09:54.680603+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"MIST DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1408443/000110465925042640/tm2513454d3_def14a.htm","published_at":"2025-04-30T00:00:00+00:00","last_checked_at":"2026-05-16T01:09:54.556389+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:andrew-r-saik","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2024-01-01 · current","organization":"Milestone Pharmaceuticals Inc.","organization_id":"milestone-pharmaceuticals-inc"},"claim_text":"Director at Milestone Pharmaceuticals Inc. (2024-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1408443/000110465925042640/tm2513454d3_def14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/andrew-r-saik#profile","url":"https://registry.alpha.ac/people/andrew-r-saik","dateModified":"2026-05-16T01:09:54.504+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/andrew-r-saik#person","name":"Andrew R. Saik","url":"https://registry.alpha.ac/people/andrew-r-saik","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Milestone Pharmaceuticals Inc.","tickerSymbol":"NASDAQ: MIST"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2024-01-01","memberOf":{"@type":"Organization","name":"Milestone Pharmaceuticals Inc.","url":"https://registry.alpha.ac/companies/milestone-pharmaceuticals-inc","tickerSymbol":"NASDAQ: MIST"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1408443/000110465925042640/tm2513454d3_def14a.htm","name":"MIST DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/andrew-r-saik"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":9,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":9,"corroborated_claims":0,"sources":3,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-16T01:09:54.504+00:00","observed_at":"2026-09-18T13:07:57.573019+00:00","freshness_days":125}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"andrew-r-saik","canonical_url":"https://registry.alpha.ac/people/andrew-r-saik"},"publication":{"published_at":"2026-09-02T02:37:24.229537+00:00","last_reviewed_at":"2026-05-16T01:09:54.504+00:00","as_of":"2026-09-18T13:07:57.573019+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/andrew-r-saik","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/andrew-r-saik","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/andrew-r-saik.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}